// App-Quantinova.ai

BSH2020‐EP‐013 : 19 courses of CPX‐351 for the treatment of AML

Researchers

Presenter

  • S. Boyd

Principal Investigators

  • M. F. McMullin

Medical Centers

  • Haematology,Belfast City Hospital,Belfast,Regno Unito

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Gastroenterology (GU)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute myelocytic leukemia

  • Myelodysplastic Syndrome

  • Constipation

  • Neutropenia

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • daunorubicin + cytarabine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved